{"entity":{"type":"insider","cik":"0001527134","url":"/insider/0001527134","json_url":"/insider/0001527134.json","name":"Sumeray Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":16,"first":"2013-04-24","last":"2014-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Sumeray Mark","source":"filing","n_filings":16,"first_seen":"2013-04-24","last_seen":"2014-03-18"}],"transactions":[{"id":6442382,"accession":"0001209191-14-021383","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-021383","line_url":"/filing/0001209191-14-021383","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":51.335,"price_display":"51.34","price_state":"stated","total_value":102670.0,"total_display":"102,670.00","total_whole":"102,670","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2014-03-18","scope":"insider","n_lines":3},{"id":6908751,"accession":"0001209191-14-011270","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-011270","line_url":"/filing/0001209191-14-011270","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":63.485,"price_display":"63.48","price_state":"stated","total_value":126970.0,"total_display":"126,970.00","total_whole":"126,970","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-14","filed_date":"2014-02-18","scope":"insider","n_lines":2},{"id":6872116,"accession":"0001209191-14-004013","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-004013","line_url":"/filing/0001209191-14-004013","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":58.63448,"price_display":"58.63","price_state":"stated","total_value":117268.96,"total_display":"117,268.96","total_whole":"117,269","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-21","scope":"insider","n_lines":2},{"id":6491268,"accession":"0001209191-14-001746","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-001746","line_url":"/filing/0001209191-14-001746","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":70.93402,"price_display":"70.93","price_state":"stated","total_value":70934.02,"total_display":"70,934.02","total_whole":"70,934","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-06","scope":"insider","n_lines":2},{"id":4652495,"accession":"0001209191-13-057350","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-057350","line_url":"/filing/0001209191-13-057350","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":66.34329,"price_display":"66.34","price_state":"stated","total_value":132686.58,"total_display":"132,686.58","total_whole":"132,687","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-16","filed_date":"2013-12-17","scope":"insider","n_lines":2},{"id":4849502,"accession":"0001209191-13-055282","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-055282","line_url":"/filing/0001209191-13-055282","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":70.42222,"price_display":"70.42","price_state":"stated","total_value":211266.66,"total_display":"211,266.66","total_whole":"211,267","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider","n_lines":2},{"id":4289481,"accession":"0001181431-13-059663","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-059663","line_url":"/filing/0001181431-13-059663","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":76.0909509,"price_display":"76.09","price_state":"stated","total_value":152181.9018,"total_display":"152,181.90","total_whole":"152,182","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider","n_lines":3},{"id":4341109,"accession":"0001181431-13-056829","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-056829","line_url":"/filing/0001181431-13-056829","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":83.28022857142857,"price_display":"83.28","price_state":"stated","total_value":291480.8,"total_display":"291,480.80","total_whole":"291,481","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-05","scope":"insider","n_lines":3},{"id":5294147,"accession":"0001181431-13-054055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-054055","line_url":"/filing/0001181431-13-054055","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":80.3295,"price_display":"80.33","price_state":"stated","total_value":160659.0,"total_display":"160,659.00","total_whole":"160,659","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-16","scope":"insider","n_lines":2},{"id":4883656,"accession":"0001181431-13-053083","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-053083","line_url":"/filing/0001181431-13-053083","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":93.167498,"price_display":"93.17","price_state":"stated","total_value":326086.243,"total_display":"326,086.24","total_whole":"326,086","shares_owned_after":1965.0,"shares_owned_after_display":"1,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-07","filed_date":"2013-10-08","scope":"insider","n_lines":3},{"id":5359662,"accession":"0001181431-13-049702","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-049702","line_url":"/filing/0001181431-13-049702","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":89.77451,"price_display":"89.77","price_state":"stated","total_value":179549.02,"total_display":"179,549.02","total_whole":"179,549","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-09-18","scope":"insider","n_lines":4},{"id":5359396,"accession":"0001181431-13-045734","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-045734","line_url":"/filing/0001181431-13-045734","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":88.7063,"price_display":"88.71","price_state":"stated","total_value":177412.6,"total_display":"177,412.60","total_whole":"177,413","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-20","scope":"insider","n_lines":3},{"id":5359043,"accession":"0001181431-13-040154","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-040154","line_url":"/filing/0001181431-13-040154","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":78.7728316,"price_display":"78.77","price_state":"stated","total_value":157545.6632,"total_display":"157,545.66","total_whole":"157,546","shares_owned_after":742.0,"shares_owned_after_display":"742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-16","scope":"insider","n_lines":3},{"id":4626365,"accession":"0001181431-13-035721","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-13-035721","line_url":"/filing/0001181431-13-035721","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":65.26999413333333,"price_display":"65.27","price_state":"stated","total_value":391619.9648,"total_display":"391,619.96","total_whole":"391,620","shares_owned_after":4191.0,"shares_owned_after_display":"4,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider","n_lines":6},{"id":5416096,"accession":"0001181431-13-028717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-028717","line_url":"/filing/0001181431-13-028717#line-2","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":47.3217,"price_display":"47.32","price_state":"stated","total_value":283930.2,"total_display":"283,930.20","total_whole":"283,930","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider"},{"id":5108276,"accession":"0001181431-13-023248","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-023248","line_url":"/filing/0001181431-13-023248","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001527134","owner_name":"Sumeray Mark","owner_display_name":"Sumeray Mark","owner_url":"/insider/0001527134","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":40.74183166666667,"price_display":"40.74","price_state":"stated","total_value":244450.99,"total_display":"244,450.99","total_whole":"244,451","shares_owned_after":2150.0,"shares_owned_after_display":"2,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-22","filed_date":"2013-04-24","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":43,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Officer (Chief Medical Officer)","n_filings":16,"first_seen":"2013-04-24","last_seen":"2014-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001527134","retrieved_at":"2026-08-25T20:18:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}